ADAMTS13 and Thrombocytopenia: Mutations in ADAMTS13 can be homozygous or compound heterozygous, which can result in either reduced production or increased clearance of the enzyme, leading to severe deficiency, an inability to cleave UL vWF multimers, platelet hyperaggregation, and consumptive thrombocytopenia [16].